|
|
|
Volumn 57, Issue 2, 2002, Pages
|
|
The safe harbor provision of the Hatch-Waxman Act: Present scope, new possibilities, and international considerations
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ERYTHROPOIETIN;
GENERIC DRUG;
NEW DRUG;
COURT;
DRUG APPROVAL;
DRUG COST;
DRUG INDUSTRY;
DRUG MANUFACTURE;
FOOD AND DRUG ADMINISTRATION;
GOOD MANUFACTURING PRACTICE;
PATENT;
REVIEW;
CANADA;
DRUG APPROVAL;
EUROPE;
FORECASTING;
HUMANS;
INTERNATIONAL COOPERATION;
JAPAN;
LEGISLATION, DRUG;
QUALITY CONTROL;
THERAPEUTIC EQUIVALENCY;
UNITED STATES;
|
|
EID: 18644370813
PISSN: 1064590X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (3)
|
|
References (0)
|
